Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

Yozo SatoDepartment of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan

Hirokazu WatanabeDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, JapanCorrespondence[email protected]

Miyuki SoneDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

Hiroaki OnayaDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

Noriaki SakamotoDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

Keigo OsugaDepartment of Diagnostic Radiology, Osaka University Graduate School of Medicine, Osaka, Japan

Masahide TakahashiDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

Yasuaki AraiDepartment of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

Your download is now in progress and you may close this window